Future Visions

Through our involvement in large-scale clinical research initiatives such as LC-SCRUM, we have developed extensive expertise in clinical research infrastructure, data operations, and research management that connects research, clinical practice, and drug development. Building on this foundation, we are expanding our capabilities into clinical development support.

 

LC-SCRUM-CD, a new initiative led by the National Cancer Center, is designed to accelerate clinical development by leveraging existing genomic screening infrastructure. By rapidly identifying eligible patients and connecting them to appropriate clinical trials, this framework is expected to improve trial efficiency, shorten development timelines, and expand patient access to new treatment opportunities. Drawing on our experience in clinical data infrastructure and research operations, we will contribute to the successful implementation and operation of this next-generation clinical development platform.

 

In addition, we are expanding our services for pharmaceutical companies, including patient screening for clinical trials, identification of eligible participants, and operational support for trial enrollment. Through these efforts, we aim to address one of the major challenges in clinical development  - patient recruitment  - while improving the speed and efficiency of clinical trials.

 

Going forward, we will continue to expand our role from supporting research infrastructure to enabling broader clinical development initiatives through the integration of data, operational expertise, and collaborative research networks.

 

We remain committed to advancing precision medicine and accelerating the development of innovative therapies through sustainable clinical research infrastructure and data-driven collaboration.